Could a simple protein test unlock the secrets of joint disease?
NCT ID NCT07751263
First seen Aug 07, 2026 · Last updated Aug 07, 2026
Summary
This study looks at whether levels of a protein called 15-PGDH in the blood and joint fluid are linked to the severity of osteoarthritis and ankylosing spondylitis. Researchers will measure 15-PGDH in about 51 adults with these conditions and compare it with ultrasound images and clinical signs of joint damage. The goal is to see if this protein could serve as a marker for disease activity and severity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If 15-PGDH levels track disease activity, it could become a simple blood test to help monitor joint damage and guide treatment.
- What could go wrong
- This is a small observational study, so it may not prove cause and effect. The findings might not apply to all patients or lead to a practical test.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Can discarded bone reveal the secrets to stronger bones?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Ear cartilage to the rescue? a tiny biopsy could rebuild knees